Immunotherapy: a new era in small-cell lung cancer
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference15 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. What's new in SCLC? A review;Oronsky;Neoplasia,2017
3. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages;Wang;Sci Rep,2017
4. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer;Stahel;Ann Oncol,2011
5. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study;Clinical and Translational Medicine;2024-06
2. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC;Translational Oncology;2024-01
3. Ultrasensitive photoelectrochemical sensing platform for detection of neuron specific enolase based on inhibition effect of CoSnO3 nanobox toward SnO2/Mn0.05Cd0.95S composites;Talanta;2023-02
4. Neuroendocrine Neoplasms of the Lung;The Thorax;2023
5. Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system;The Lancet Regional Health - Americas;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3